echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The UK will completely ban the sale of proprietary Chinese medicines, which will have little impact on domestic pharmaceutical companies

    The UK will completely ban the sale of proprietary Chinese medicines, which will have little impact on domestic pharmaceutical companies

    • Last Update: 2013-09-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    September 9, 2013 source: Securities Daily September 8, according to media reports, the UK drug administration said it plans to ban the sale of Chinese patent medicines in the UK from the beginning of next year Previously, the UK Drug Administration issued a warning to remind the risk of toxicity of traditional Chinese medicine The news once again aroused the attention of consumers and investors on traditional Chinese medicine In response, Liu Yaming, an analyst at Founder Securities, said in an interview with Securities Daily: "this news has little impact on domestic traditional Chinese medicine enterprises The market of domestic traditional Chinese medicine enterprises is mainly in China, and domestic traditional Chinese medicine has not entered the mainstream drug market in Europe and the United States." The UK said no to Chinese patent medicines on August 20, the UK Drug Administration issued a warning on its official website, reminding domestic consumers to carefully select some traditional Chinese medicines that have not been officially registered in the UK, saying that these traditional Chinese medicines contain high levels of harmful toxins, including lead, mercury, arsenic, etc Yesterday, according to domestic media reports, the UK drug administration has informed the Chinese Medicine Societies and some large Chinese medicine stores to report the inventory of Chinese patent medicines The agency said it planned to ban the sale of Chinese patent medicines in the UK from early next year Whether to use Chinese patent medicine or not is also a hot topic in China Previously, there was a rumor that "Beijing Chaoyang Hospital will prohibit the existence and use of any traditional Chinese medicine injection preparation in the hospital by administrative means", which had caused the stock price of relevant domestic pharmaceutical enterprises to fluctuate to varying degrees In response, Chaoyang Hospital has responded to the media that the news is not true, because the hospital has never had traditional Chinese medicine injection preparations in its history A pharmaceutical industry analyst, who asked not to be named, told the Securities Daily that the use of traditional Chinese medicine injections is determined by the habits of each place It is a practice in Beijing area hospitals not to use traditional Chinese medicine injections Analysts said the impact was small for the UK drug administration's announcement, which Liu said had little impact on Chinese medicine listed companies "The scale of the global traditional Chinese medicine industry is not large, foreign traditional Chinese medicine accounts for 70% in Japan and South Korea, and the European and American regions are not the mainstream consumer markets of traditional Chinese medicine." "The sales market of domestic traditional Chinese medicine enterprises is still in China, and the export proportion is not high." According to Liu Yaming However, will the implementation of this policy in the UK affect other European and American regions? Liu Yaming said the impact is also small Many traditional Chinese medicines are sold as food supplements in the United States, and the main sales group is Chinese "There is still a long way to go for the internationalization of domestic traditional Chinese medicine." A person in the industry who did not want to be named told reporters that the export of traditional Chinese medicine has been hit repeatedly As a big country of traditional Chinese medicine, the export of traditional Chinese medicine accounts for only 3% - 5% of the world market of traditional Chinese medicine However, the above-mentioned medical industry analyst who did not want to be named told reporters that the main export countries of domestic pharmaceutical enterprises are Japan, Singapore and other Southeast Asian countries It should be considered rationally that traditional Chinese medicine plays an important role in China's pharmaceutical industry Data shows that by the end of 2012, the total assets of China's pharmaceutical industry were 16408 billion yuan Among them, the original chemical medicine is 330 billion 500 million yuan, with an increase of 16.6% year on year; the chemical preparation is 508 billion 900 million yuan, with an increase of 24.7%; the Chinese herbal pieces are 102 billion yuan, with an increase of 26.4%; the Chinese patent medicine is 413 billion 600 million yuan, with an increase of 21.3%; the biochemical medicine is 185 billion 300 million yuan, with an increase of 20.5% according to the data, according to the industry classification of Shenyin Wanguo, there are 55 shares in the domestic A share market Chinese medicine listed companies, including Yunnan Baiyao, China Resources Sanjiu, Tongrentang, Pianzihuang, Guizhou bailing, etc The 55 listed Chinese medicine companies achieved a total net profit of 12.7 billion yuan attributable to the shareholders of the parent company last year In the first half of this year, the 55 listed Chinese medicine companies achieved a net profit of 8.19 billion yuan attributable to the shareholders of the parent company, up 25% from 6.53 billion yuan in the same period last year In the first half of this year, Kangmei Pharmaceutical Co., Ltd., Yunnan Baiyao Pharmaceutical Co., Ltd., Tianshili Pharmaceutical Co., Ltd., and China Resources Sanjiu Pharmaceutical Co., Ltd ranked first among the listed Chinese medicine companies in terms of net profits attributable to shareholders of the parent company In addition, 42 listed traditional Chinese medicine companies achieved performance growth, including Baiyunshan, Kangmei pharmaceutical, Yunnan Baiyao and tisley, four listed companies with more net profit growth According to media reports, at a recent summit forum, Fang Shuting, President of the China Association of traditional Chinese medicine, said that the development trend of Chinese medicine industry is good, and the output value of Chinese medicine industry is expected to reach 1 / 3 of the output value of the whole pharmaceutical industry this year For traditional Chinese medicine has been black repeatedly, the above industry told reporters that some traditional Chinese medicine may have the phenomenon of heavy metal exceeding the standard, but we should also see the positive role of traditional Chinese medicine, "traditional Chinese medicine still has many iron fans"  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.